Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2000
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP0801642B1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
12/20/2000EP0543858B1 Benzimidazole derivatives, process for their preparation and application
12/20/2000CN1059668C Process for producing N-aliphatic substituted p-phenylenediamines
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162425 A keratin-reducing agent without allergic and sensitizing reactions
12/14/2000WO2000075132A1 Process for preparing a 10,11-methanodibenzosuberane derivative
12/14/2000WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000075105A1 Valency platform molecules comprising aminooxy groups
12/14/2000WO2000047547A3 Cycloalkyl amine compounds and uses thereof
12/14/2000WO2000046187A3 Antizyme modulators and their use
12/14/2000CA2378735A1 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000CA2376057A1 Valency platform molecules comprising aminooxy groups
12/14/2000CA2375283A1 Process for preparing a 10,11-methanodibenzosuberane derivative
12/13/2000EP1059296A1 Lewis adducts of aluminum organyls for preparation of alumina films by CVD
12/13/2000EP0874834B1 Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity
12/12/2000US6159973 Aromatic amides, their preparation process, the compositions containing them and their use as pesticides
12/12/2000CA2160881C 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
12/12/2000CA2131186C Isosteric antiherpes peptide derivatives
12/12/2000CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
12/07/2000WO2000073292A1 Biaryl compounds
12/07/2000WO2000073291A1 Process for producing piperidine
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073265A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000073257A1 Derivatives of butyric acid and uses thereof
12/07/2000WO2000072920A1 Substituted biaryl ether compounds
12/07/2000WO2000072834A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/07/2000WO2000072800A2 Il-8 receptor antagonists
12/07/2000CA2375822A1 Substituted biaryl ether compounds
12/07/2000CA2375674A1 Biaryl compounds
12/07/2000CA2375667A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/06/2000EP1057815A1 Cyclic amide compounds
12/06/2000EP1056743A1 Benzamine derivatives
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000EP1056720A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
12/05/2000US6156899 N-aryl-2-hydroxyalkylamido compositions for inducing/stimulating hair growth and/or retarding hair loss and/or for treating hyperseborrhea and/or acne
12/05/2000US6156889 Reagent useful for cleaving a protected functional group
12/05/2000US6156794 Nervous system disorders or alzheimers disease
12/05/2000US6156769 Antipruitus drugs for mammals
12/05/2000US6156768 Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/05/2000US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156516 Method for screening substance inhibiting activation of NF-κB
11/2000
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071500A1 Halogen compounds
11/30/2000WO2000044379A3 Methods for restoring and/or enhancing accommodation in pseudo phakia
11/30/2000WO2000032583A9 Antitumor dibenzofluorene derivatives
11/30/2000CA2382751A1 Inhibitors of factor xa
11/30/2000CA2374947A1 Inhibitors of factor xa
11/30/2000CA2374820A1 Inhibitors of factor xa
11/30/2000CA2374793A1 Inhibitors of factor xa
11/30/2000CA2374650A1 Inhibitors of factor xa
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/29/2000EP1055658A2 Process for cis-1- 2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl pyrrolidine
11/29/2000EP1054878A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000CN1275122A Process to produce oxazolidinones
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/28/2000US6153748 Method for hydrogenating compounds from the group of imines or enamines
11/28/2000US6153622 Estrogen agonists/antagonists
11/28/2000US6153612 Sulfonamide inhibitors of matrix metalloproteinases
11/28/2000US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153178 A keratin-reducing agent containing a mercapto acetamide with cyclic amine group for hair styling
11/23/2000WO2000069839A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000043354A3 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/23/2000WO2000020441A3 Cyclic peptides as antifungal agents
11/23/2000DE19922934A1 New 5,5-dihalo- or 4,5,5-trihalo-4-pentenoic acid derivatives, useful as bactericides, fungicides, insecticides, acaricides and nematocides, especially plant fungicides
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/22/2000EP1053226A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000EP0720852B1 Remedy for nervous diseases
11/22/2000EP0699180B1 Bicyclic amide derivatives and their use as muscle relaxants
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150413 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders, as well as mammalian skin and hair conditions; 4-(4-(biphenyl-2-yl)but-3-en-1-ynyl)benzoic acid, for example
11/21/2000US6150397 5-aroylnaphthalene derivatives as anti-inflammatory agents
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150129 Antimicrobial determination of N-(aminoalkyl) and/or N-(Amidoalkyl) dinitrogen heterocyclic compositions
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 341